Training future scientists in benign urology at Stanford
Official title: Multidisciplinary K12 Urologic Research at Stanford (KUReS) Career Development Program
Funded at Stanford University · NIH-10892291 · Data updated 2026-11-12
This program is designed to help future scientists who want to study and improve treatments for non-cancerous urology issues by providing them with hands-on training and support from experienced mentors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $434,440 |
| NIH project number | 5K12DK137162-02 |
| Project ID | NIH-10892291 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals interested in urology and those who may be affected by benign urological disorders.
✕Less likely to help
Patients with severe urological conditions or those requiring immediate clinical interventions may not benefit directly from this research.
What this research studies
This program aims to develop the next generation of highly qualified scientists in the field of benign urology. It provides training and mentorship to MD, MD/PhD, and PhD scholars, equipping them with the skills necessary to become independent investigators. The program emphasizes a collaborative approach, involving faculty from various disciplines to enhance the educational experience. Scholars will engage in hands-on research and receive individualized education tailored to their specific needs.
Why it matters
Potential benefit: If successful, this research could lead to advancements in the treatment and understanding of benign urological conditions.
How similar studies have gone: Similar training programs have successfully produced qualified researchers in various medical fields, indicating a strong potential for success in this approach.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Liao, Joseph C — Stanford University
- Study coordinator: Liao, Joseph C
Related research
Other NIH-funded projects on the same topics.
-
Multimodal AI to predict CAR-T patient response and guide safer, smarter cell design
A Stanford team is building AI tools that use patient and CAR-T cell data to predict how well a CAR-T therapy will work and what design changes might boost effectiveness and safety for people with cancer.
-
Community-driven model to reduce overdose deaths through smarter resource use
A Stanford-led project uses a data-driven model to help counties pick the best ways to prevent opioid and stimulant overdoses and save lives.
-
Center for Dissemination and Implementation at Stanford: Research Core
A Stanford-based program is advancing how evidence-based addiction treatments are implemented across settings to help people with substance use disorders receive better care.
-
Center for Dissemination and Implementation At Stanford (C-DIAS)
A center-based program at Stanford aims to speed people who need addiction treatments to get evidence-based care.
-
Mitochondrial structure and neuron health in Alzheimer's and ALS
This grant studies how mitochondrial cristae structure in neurons is controlled and how its disruption may contribute to diseases like Alzheimer's and ALS.
-
Pediatric EMS seizures: simpler age-based midazolam dosing
A nationwide trial at EMS agencies tests whether using fixed, age-based dosing of midazolam for seizures in children improves treatment speed and safety.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.